The Leiden biotech company VarmX will receive 17.5 million euros from an innovation program of the European Union. The money is intended to increase the production of a drug inspired by snake venom. It prevents serious bleeding in patients taking blood thinners, especially during emergency surgery.
–
Related posts:
Proven To Treat Uric Acid, Use The Following Mixture When It Feels Pain and Swelling
Elite Nightclubs Become the Biggest Center of Corona Spread in Thailand
Corona crisis in North Rhine-Westphalia: Outdoor pools open from May 20th
The Original Size of the Sun, the Star at the Center of the Solar System
